Cargando…
Conversion to generic cyclosporine A in stable chronic patients after heart transplantation
BACKGROUND: Cyclosporine A (CSA) is a narrow therapeutic index drug. Available CSA products differ in the constitution of their emulsion. To compare intra-individual differences after a conversion to a generic CSA, a retrospective single-center study was initiated. METHODS: Twenty adult stable chron...
Autores principales: | Kraeuter, Maximilian, Helmschrott, Matthias, Erbel, Christian, Gleissner, Christian A, Frankenstein, Lutz, Schmack, Bastian, Ruhparwar, Arjang, Ehlermann, Philipp, Katus, Hugo A, Doesch, Andreas O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849002/ https://www.ncbi.nlm.nih.gov/pubmed/24348018 http://dx.doi.org/10.2147/DDDT.S54245 |
Ejemplares similares
-
Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation
por: Helmschrott, Matthias, et al.
Publicado: (2015) -
Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy
por: Rivinius, Rasmus, et al.
Publicado: (2014) -
Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen
por: Helmschrott, Matthias, et al.
Publicado: (2014) -
Effects of vildagliptin (Galvus®) therapy in patients with type 2 diabetes mellitus after heart transplantation
por: Gueler, Ibrahim, et al.
Publicado: (2013) -
Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation
por: Rivinius, Rasmus, et al.
Publicado: (2016)